Our History

1980

Decree of establishing EIPICO.

1985

Starting production according to GMP regulations.
with total Production of 19.7M and total Sales of 15.4M (1985).

1985- 1990

Started Exporting to the Middle East and North Africa (MENA) region including Yemen, Saudi Arabia, Libya and Sudan.
with total Production of 100.5M and total Sales of 97.7M (1990).

1990 - 1995

Penetrating Eastern Europe countries such as Romania and Asian countries including the Commonwealth of Independent States (CIS) countries.
With total Production of 261.6M and total Sales of 249.3M (1995).

1995 - 2000

Establishing the plastic factory and starting production.
Establishing the Biotechnology Center with the mission of being the First, Biggest and Most Advanced Facility in Egypt.
with total Production of 415M and total Sales of 388.7M (2000).

2000- 2005

Establishing EIACO as an Egyptian investment company for manufacturing medical ampoules, EIPICO is the main investor.
With total Production of 755.1M and total Sales of 677M (2005).

2005- 2010

Establishing Batterjee Pharma and starting production in 2009, located in Saudi Arabia.
EIPICO exports to 40 countries Worldwide.
with total Production of 1123.4M and total Sales of 1100.5M (2010).

2010 -2015

EIPICO launching Factory 2 plant to fulfil the ever-growing demand of both national and international markets.
WHO prequalified the Cephalosporin department.
with total Production 1477.6M and total Sales 1329.9M (2015).

2020

Starting the implementation of EIPICO 3 factory, the largest and first factory in Egypt and the Middle East for manufacturing the "Biologicals & Biosimilars" on 10,500 m2 with investments of 100 Million USD